Market Overview

UPDATE: Morgan Stanley Reiterates On McKesson Following Investor Day

Share:
Related MCK
NovaBay Signs Avenova Distribution Agreement with Cardinal Health
Joe Terranova's Picks For 2015
McKesson declares $0.24 dividend (Seeking Alpha)

In a report published Thursday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on McKesson (NYSE: MCK), and raised the price target from $197.00 to $205.00.

In the report, Morgan Stanley noted, “Investor day showcased MCK's mkt leadership, favorable ind trends and mgmt breadth. Incr margin targets highlight expansion levers, complemented by cap deployment. W/ strong generic inflation, Celesio & PSS synergies, and generic scale oppty, we view MCK as best positioned in group. PT to $205.”

McKesson closed on Wednesday at $187.35.

Latest Ratings for MCK

DateFirmActionFromTo
Jan 2015JP MorganMaintainsOverweight
Jan 2015BarclaysMaintainsOverweight
Dec 2014Bank of AmericaMaintainsBuy

View More Analyst Ratings for MCK
View the Latest Analyst Ratings

Posted-In: Morgan Stanley Ricky R. GoldwasserAnalyst Color Price Target Analyst Ratings

 

Related Articles (MCK)

Around the Web, We're Loving...

Get Benzinga's Newsletters